These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32228231)

  • 1. Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial.
    Kondoh Y; Azuma A; Tagawa J; Homma S
    Am J Respir Crit Care Med; 2020 Jul; 202(1):151-152. PubMed ID: 32228231
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial.
    Horita N; Takeshi K
    Am J Respir Crit Care Med; 2020 Jul; 202(1):150-151. PubMed ID: 32228230
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial.
    Kondoh Y; Azuma A; Inoue Y; Ogura T; Sakamoto S; Tsushima K; Johkoh T; Fujimoto K; Ichikado K; Matsuzawa Y; Saito T; Kishi K; Tomii K; Sakamoto N; Aoshima M; Araya J; Izumi S; Arita M; Abe M; Yamauchi H; Shindoh J; Suda T; Okamoto M; Ebina M; Yamada Y; Tohda Y; Kawamura T; Taguchi Y; Ishii H; Hashimoto N; Abe S; Taniguchi H; Tagawa J; Bessho K; Yamamori N; Homma S
    Am J Respir Crit Care Med; 2020 May; 201(9):1110-1119. PubMed ID: 31917621
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Kobayashi
    Kondoh Y; Azuma A; Tagawa J; Yamamori N; Homma S
    Am J Respir Crit Care Med; 2020 Jun; 201(11):1450-1451. PubMed ID: 32150449
    [No Abstract]   [Full Text] [Related]  

  • 5. Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis.
    Kobayashi T; Hataji O; Fujimoto H; D'Alessandro-Gabazza C; Yasuma T; Gabazza EC
    Am J Respir Crit Care Med; 2020 Jun; 201(11):1449-1450. PubMed ID: 32150439
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Call to Arms.
    Kreuter M; Maher TM
    Am J Respir Crit Care Med; 2020 May; 201(9):1030-1032. PubMed ID: 31978310
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Isshiki T; Sakamoto S; Homma S
    Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31137593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: A historically controlled study.
    Sakamoto S; Shimizu H; Isshiki T; Sugino K; Kurosaki A; Homma S
    Respir Investig; 2018 Mar; 56(2):136-143. PubMed ID: 29548651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
    Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
    Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.
    Tsushima K; Yamaguchi K; Kono Y; Yokoyama T; Kubo K; Matsumura T; Ichimura Y; Abe M; Terada J; Tatsumi K
    Pulm Pharmacol Ther; 2014 Dec; 29(2):233-40. PubMed ID: 24836398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study.
    Furuya K; Sakamoto S; Shimizu H; Sekiya M; Kinoshita A; Isshiki T; Sugino K; Matsumoto K; Homma S
    Respir Med; 2017 May; 126():93-99. PubMed ID: 28427556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Human Thrombomodulin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Kataoka K; Taniguchi H; Kondoh Y; Nishiyama O; Kimura T; Matsuda T; Yokoyama T; Sakamoto K; Ando M
    Chest; 2015 Aug; 148(2):436-443. PubMed ID: 25811735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
    Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
    BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial design for acute exacerbations in idiopathic pulmonary fibrosis: A thorny path.
    Renzoni EA; Wells AU
    Respirology; 2019 Jul; 24(7):620-621. PubMed ID: 31094045
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply: Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Corte TJ; Ryerson CJ; Collard HR
    Am J Respir Crit Care Med; 2017 Feb; 195(4):542-543. PubMed ID: 28199161
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant human soluble thrombomodulin treatment for acute exacerbation of idiopathic pulmonary fibrosis: a retrospective study.
    Isshiki T; Sakamoto S; Kinoshita A; Sugino K; Kurosaki A; Homma S
    Respiration; 2015; 89(3):201-7. PubMed ID: 25659984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis.
    Kakugawa T; Sakamoto N; Sato S; Yura H; Harada T; Nakashima S; Hara A; Oda K; Ishimoto H; Yatera K; Ishimatsu Y; Obase Y; Kohno S; Mukae H
    Respir Res; 2016 Jul; 17(1):79. PubMed ID: 27401332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Cell Apoptosis and Amelioration of Pulmonary Fibrosis by Thrombomodulin.
    Fujiwara K; Kobayashi T; Fujimoto H; Nakahara H; D'Alessandro-Gabazza CN; Hinneh JA; Takahashi Y; Yasuma T; Nishihama K; Toda M; Kajiki M; Takei Y; Taguchi O; Gabazza EC
    Am J Pathol; 2017 Oct; 187(10):2312-2322. PubMed ID: 28739343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors.
    Simon-Blancal V; Freynet O; Nunes H; Bouvry D; Naggara N; Brillet PY; Denis D; Cohen Y; Vincent F; Valeyre D; Naccache JM
    Respiration; 2012; 83(1):28-35. PubMed ID: 21860222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between F-18 fluorodeoxyglucose uptake of noncancerous lung area and acute exacerbation of interstitial pneumonia in patients with lung cancer after resection.
    Yamamichi T; Shimada Y; Masuno R; Ohira T; Abe S; Yoshimura A; Ikeda N
    J Thorac Cardiovasc Surg; 2020 Mar; 159(3):1111-1118.e2. PubMed ID: 31587890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.